MLH1 Deficiency Down-Regulates TLR4 Expression in Sporadic Colorectal Cancer

Area of Science:

• Oncology
• Molecular Biology
• Immunology

Background:

• Mismatch repair (MMR)-deficient colorectal cancer (CRC) exhibits a more favorable prognosis compared to MMR-intact tumors.
• The underlying mechanisms for this prognostic difference, particularly the role of immune signaling pathways, require further elucidation.

Purpose of the Study:

• To investigate the relationship between MMR gene status and TLR4/MyD88 signaling in colorectal cancer.
• To explore how MMR deficiency impacts TLR4 expression and potentially influences patient outcomes.

Main Methods:

• Utilized The Cancer Genome Atlas (TCGA) databases for differential expression analysis of TLR4 in colon cancer and its correlation with MMR genes.
• Performed immunohistochemistry to assess MMR gene and TLR4 expression in 113 CRC samples.
• Quantified TLR4 mRNA expression and MLH1 epigenetic silencing in a cohort of 63 patients.
• Conducted in vitro experiments with MLH1 knockdown to assess its effect on TLR4 expression via Real-Time PCR.

Main Results:

• TLR4 expression was found to be dependent on MMR status and directly correlated with MLH1 expression.
• In vitro MLH1 silencing led to a decrease in TLR4 expression.
• These findings suggest a molecular link between MMR deficiency and altered TLR4 signaling.

Conclusions:

• MMR status significantly influences TLR4 expression in colorectal cancer.
• The observed correlation between MMR deficiency, reduced TLR4 expression, and favorable prognosis suggests a potential mechanism for improved outcomes and chemoresistance in these patients.